Synova S.A.: SYNOVA’s growth continues with new subsidiary in Germany

(DUILLIER, Switzerland): – The Swiss company Synova, manufacturer of patented water jet guided laser cutting systems, has expanded its global branch network and founded a new subsidiary in the former Mikron Germany plant in Rottweil (BW). The factory is now producing CNC-controlled Laser MicroJet machines for the high-precision machining of materials such as metals, ceramics, diamonds or composites.
A micro-machining center (MMC) including a showroom for job shop production and sales activities will be added in September. The new MMC will offer laser processing services such as cutting jobs, application tests and machine demonstrations. Two Laser MicroJet (LMJ) systems will be available for this purpose: the LCS 303 laser cutting system for 2D machining of workpieces up to 300 x 300 mm in size and, as of November, the 5-axis laser machining center LCS 305 for 3D machining.
"The Rottweil site allows us to move closer to customers in the German market, Austria and the Benelux countries and to introduce them to the unique advantages of our water jet laser technology and its numerous application possibilities," says Dr. Bernold Richerzhagen, Synova Founder and CEO. "In addition, we are in the process of expanding our customer service on site to be able to best serve customers as quickly as possible," adds Richerzhagen.
All Synova machines are based on the LMJ laser technology invented and patented by Synova that not only cools workpieces, but also efficiently washes away the removed material. The water jet maintains the laser’s focus creating a cylindrical laser beam that results in perfectly parallel walls and tight kerf widths. The LMJ process allows unprecedented quality and precision.
About Synova
Synova S.A., headquartered in Duillier, Switzerland, manufactures advanced laser cutting systems that incorporate its proprietary water jet guided laser technology (Laser MicroJetÒ) in a true industrial CNC platform. Customers benefit from significant yield and improved cutting quality as well as enhanced capabilities for precision machining a wide range of materials. For more information, visit our website at www.synova.ch.
Synova GmbH (Germany):
Berner Feld 71
78628 Rottweil, Germany
+49 (0) 741 320 70 900
info@synova-gmbh.de
Contacts
Martin TeichmannSales Manager Germany, Austria, Benelux
martin.teichmann@synova-gmbh.deImages
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
Dr. Stefanie Kesting appointed as CEO of Thyssengas7.1.2026 14:06:26 CET | Press release
Dortmund, 06.01.2026 As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength7.1.2026 08:59:31 CET | Press release
To mark its 30th anniversary, the European Spas Association (ESPA) has released a special commemorative publication highlighting the strategic role of Europe’s medical spas and climate-health resorts in an era defined by prevention, longevity and sustainable wellbeing.
Forum for a self-reliant and self-determined Europe - the "Sovereign Europe Forum"23.12.2025 08:40:47 CET | Press release
Entrepreneurs, top managers and leaders from United Europe e.V. and European Forum Alpbach (EFA) are founding the Sovereign Europe Forum i.G.
Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release
youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom


